Generic semaglutide tablets: what the question really means for UK patients

Why there is no generic version, and why that matters right now

A generic medicine becomes possible once the originator's patent lapses and regulators have assessed a copycat manufacturer's data. That has not happened with semaglutide for weight management in the UK. Novo Nordisk holds the current licence, the formulation is complex, and the MHRA has not authorised any equivalent product from another manufacturer.

This matters practically because searches for "generic semaglutide tablets" often lead to overseas websites or unverified sellers claiming to offer the same active ingredient at a lower price. The MHRA has warned repeatedly that medicines obtained this way carry serious risks: unknown concentration, contamination, and outright counterfeit contents. Fake pens have previously been found to contain insulin rather than the stated medicine. Report any suspect seller at the MHRA's Yellow Card portal, which handles both side-effect reports and concerns about illegal supply.

The short version: if you are searching for a cheaper oral semaglutide option, the only safe route is a prescription for the licensed Wegovy tablet through a pharmacy you can verify on the GPhC register, and you can find a fuller explanation of what that involves on our page covering semaglutide tablets.

What the licensed oral semaglutide tablet actually is

Wegovy tablets use a co-formulation of semaglutide and an absorption enhancer called SNAC, which allows the active ingredient to cross the gut wall in meaningful amounts. That is not a simple process to replicate, and it is one reason a straightforward generic copy is harder to produce than it might be for, say, a conventional paracetamol tablet.

The dose ladder starts at 1.5 mg daily and moves through 4 mg and 9 mg to a 25 mg maintenance dose, spending at least a month at each level. The MHRA approval in June 2026 made the UK the first country in Europe to license this formulation for weight management. In the pivotal OASIS 4 trial, participants lost an average of around 13.6% of their body weight over 64 weeks; those who remained fully adherent to treatment saw losses of roughly 17%, though that figure applies specifically to the adherent subgroup rather than the overall population. You can read more about the evidence and what the tablet involves on our overview of oral semaglutide.

There is no refrigeration requirement, which makes it more convenient for travel or if keeping an injection pen cold is difficult. The tablet is taken first thing in the morning on an empty stomach with a small amount of plain water, then a minimum of 30 minutes before eating, drinking anything else, or taking other medicines.

Rybelsus tablets: the semaglutide confusion worth clearing up

Some people searching for generic semaglutide tablets have come across Rybelsus, which is also an oral semaglutide product made by Novo Nordisk. The tablet strengths are 3 mg, 7 mg and 14 mg, and it is licensed in the UK for type 2 diabetes management, not weight loss.

These two products share the same active ingredient but have different licensed indications, different dose ranges, and different clinical evidence bases. Rybelsus is not a generic of Wegovy, and it is not interchangeable with the weight-loss tablet in either dose or clinical purpose. Pages on the 3 mg tablet and the 7 mg tablet explain both of those strengths in the correct diabetes context.

If your goal is weight management, the relevant medicine is the Wegovy tablet, assessed and prescribed for that specific purpose. Worth checking: a prescriber looking at your history, medicines, and health conditions is the starting point, not a product page.

Cost context and what a prescription actually covers

Part of the appeal of the idea of a generic is price. The question of what oral semaglutide costs in the UK is a reasonable one, and the answer is that private treatment prices vary by provider and dose. What a legitimate price always includes is a clinical assessment, a prescription from a registered prescriber, and a supply chain regulated by the MHRA. No legitimate pharmacy discounts prescription medicines with voucher codes or promotional offers.

If you are weighing up timing, some patients find it useful to plan their first order around a regular monthly date so repeat orders fit their routine. There is no subscription at nume: each order is clinically reviewed individually, so there is no auto-renewal to manage.

For anyone who qualifies clinically, the Wegovy tablet is a prescription-only medicine under UK law, which means it requires a consultation with a registered prescriber before supply. Our clinical team includes GPhC-registered Independent Prescribers who review every consultation personally. To explore whether this treatment is appropriate for your situation, you can read about the full range of options on our weight-loss treatments overview.